ImmunityBio (IBRX) Retained Earnings (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Retained Earnings of -$4.4 billion for Q1 2026, down 24.38% year-over-year from -$5.8 billion in Q1 2025, and down 15155.35% quarter-over-quarter from $29.0 million in Q4 2025.
ImmunityBio (IBRX) Retained Earnings (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Retained Earnings for 13 consecutive years, with -$4.4 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 24.38% year-over-year to -$4.4 billion; the TTM figure through Mar 2026 stood at -$4.4 billion (down 24.38% YoY), while the FY2025 annual figure was $29.0 million, up 100.86% from the prior year.
- Retained Earnings retreated to -$4.4 billion in Q1 2026 per IBRX's latest filing, from $29.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $29.0 million in Q4 2025 and bottomed at -$4.4 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$2.3 billion across 5 years, with a median of -$2.6 billion in 2023.
- On a YoY basis, Retained Earnings climbed as much as 100.86% in 2025 and fell as far as 50069814.29% in 2025.
- ImmunityBio's Retained Earnings stood at -$2.4 billion in 2022, then retreated by 24.52% to -$3.0 billion in 2023, then declined by 13.96% to -$3.4 billion in 2024, then soared by 100.86% to $29.0 million in 2025, then tumbled by 15155.35% to -$4.4 billion in 2026.
- Business Quant data shows IBRX's Retained Earnings at -$4.4 billion in Q1 2026, $29.0 million in Q4 2025, and -$3.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | -4.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.60 Bn |
| Mar 31, 2026 | -4.36 Bn |
| Dec 31, 2025 | 28.96 Mn |
| Sep 30, 2025 | -3.70 Bn |
| Jun 30, 2025 | -3.60 Bn |
| Mar 31, 2025 | -3.50 Bn |
| Dec 31, 2024 | -3.38 Bn |
| Sep 30, 2024 | -3.32 Bn |
| Jun 30, 2024 | -3.20 Bn |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -2.96 Bn |
| Sep 30, 2023 | 792,000.00 |
| Jun 30, 2023 | -2.63 Bn |
| Mar 31, 2023 | -33,000.00 |
| Dec 31, 2022 | -2.38 Bn |
| Sep 30, 2022 | -2.30 Bn |
| Jun 30, 2022 | -2.16 Bn |
| Mar 31, 2022 | -2.10 Bn |
| Dec 31, 2021 | -1.96 Bn |
| Sep 30, 2021 | 53,000.00 |